Kim Kwan Il, Lee Kyung Hee, Kim Tae Ryung, Chun Yong Soon, Lee Tae Hoon, Choi Hye Young, Park Heung Kyu
Department of Surgery, Gachon University Gil Medical Center, 21 Namdong-daero 774-beon-gil, Namdong-gu, Incheon, 405-760, Korea.
Department of Radiology, Gachon University Gil Medical Center, Incheon, Korea.
Breast Cancer. 2016 May;23(3):471-8. doi: 10.1007/s12282-015-0589-8. Epub 2015 Feb 5.
The presence of microcalcification on mammography is one of the earliest signs in breast cancer detection. However, it is difficult to distinguish malignant calcifications from benign calcifications. The aim of this study is to evaluate correlation between changing patterns of microcalcification on screening mammography and malignant breast lesions.
Medical records and diagnostic images of 67 women who had previously undergone at least two digital mammograms at least 6 months apart and underwent mammography-guided needle localization and surgical excision between 2011 and 2013 were retrospectively reviewed and analyzed.
Breast cancer was detected in the surgical specimens of 20 patients (29.9 %). Annual change of extent of microcalcification on mammography showed statistically significant correlation with pathologic outcome (P = 0.023). The changing pattern of new appearance or increased extent of microcalcification on mammography had positive predictive value of 54.8 % for breast cancer, and it was a statistically significant predictor for breast cancer (P = 0.012). Shape or number change of microcalcification without increased extent had less accurate predictive value for breast cancer, particularly in women younger than 50 years (P < 0.001).
This study showed that the pattern of increased extent of microcalcification on screening mammography was a significant predictor for breast cancer. We suggest that mammography-guided needle localization and surgical excision should be considered when increased extent of microcalcification is observed on screening mammography and closed follow-up without pathologic confirmation can be permitted if absence of extension of microcalcification was confirmed in women younger than 50 years.
乳腺钼靶检查中微钙化的出现是乳腺癌检测的最早迹象之一。然而,很难将恶性钙化与良性钙化区分开来。本研究的目的是评估筛查乳腺钼靶中微钙化变化模式与乳腺恶性病变之间的相关性。
回顾性分析了67名女性的病历和诊断图像,这些女性在2011年至2013年间至少间隔6个月接受了两次数字乳腺钼靶检查,并接受了乳腺钼靶引导下的针定位和手术切除。
20例患者(29.9%)的手术标本中检测到乳腺癌。乳腺钼靶上微钙化范围的年度变化与病理结果具有统计学显著相关性(P = 0.023)。乳腺钼靶上新出现或范围增加的微钙化变化模式对乳腺癌的阳性预测值为54.8%,是乳腺癌的统计学显著预测指标(P = 0.012)。微钙化形状或数量改变但范围未增加对乳腺癌的预测价值较低,尤其是在50岁以下的女性中(P < 0.001)。
本研究表明,筛查乳腺钼靶上微钙化范围增加的模式是乳腺癌的重要预测指标。我们建议,当在筛查乳腺钼靶上观察到微钙化范围增加时,应考虑进行乳腺钼靶引导下的针定位和手术切除;对于50岁以下女性,如果确认微钙化没有扩展,则可以在不进行病理确认的情况下进行密切随访。